Fidelity Investments’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78K	Sell	7,025 -156	-2%	-$1.97K	﹤0.01%	3905
2025 Q4	$119K	Buy	7,181 +182	+3%	+$2.6K	﹤0.01%	3669
2025 Q3	$82.4K	Buy	6,999 +1,118	+19%	+$11.5K	﹤0.01%	3745
2025 Q2	$56.4K	Sell	5,881 -503,701	-99%	-$2.79M	﹤0.01%	3843
2025 Q1	$3.2M	Sell	509,582 -291,819	-36%	-$1.77M	﹤0.01%	2302
2024 Q4	$6.51M	Sell	801,401 -502,713	-39%	-$6.23M	﹤0.01%	2072
2024 Q3	$23.6M	Buy	1,304,114 +1,301,458	+49,001%	+$18.2M	﹤0.01%	1652
2024 Q2	$27.4K	Buy	2,656 +572	+27%	+$5.89K	﹤0.01%	3924
2024 Q1	$22.1K	Sell	2,084 -1,249	-37%	-$10.6K	﹤0.01%	3973
2023 Q4	$30.4K	Buy	3,333 +1,444	+76%	+$12.4K	﹤0.01%	3747
2023 Q3	$19.6K	Sell	1,889 -35,435	-95%	-$486K	﹤0.01%	3816
2023 Q2	$534K	Buy	37,324 +36,556	+4,760%	+$421K	﹤0.01%	2633
2023 Q1	$5.48K	Buy	768 +73	+11%	+$641	﹤0.01%	4362
2022 Q4	$7.8K	Sell	695 -520	-43%	-$5.36K	﹤0.01%	4104
2022 Q3	$13K	Buy	1,215 +837	+221%	+$7.97K	﹤0.01%	3993
2022 Q2	$3K	Sell	378 -105	-22%	-$1.08K	﹤0.01%	4482
2022 Q1	$7K	Buy	+483	New	+$7.8K	﹤0.01%	4346
2021 Q4	–	Sell	-154,200	Closed	-$4.95M	–	4797
2021 Q3	$4.95M	Buy	+154,200	New	+$5.12M	﹤0.01%	2372